CD274 and oropharynx cancer: Tumors from patients with HPV-positive oropharyngeal cancer have been shown to have a higher frequency of PD-L1–expressing ICs than those from patients with HPV-negative oropharyngeal cancer, concomitant with a significantly higher 5-year OS rate (25).